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Palatine and pharyngeal tonsils are immune reactive lymphoid organs that manifest specific anti-
bodies and B/T-cell activity to respond to a variety of antigens. They perform humoral and cellular 
immune functions. The possible effects of adenotonsillectomy upon the immune system remain 
controversial.
Objective: To study the short and long-term impacts of tonsillectomy upon the cellular and humoral 
immunity of children.
Method: This longitudinal prospective study included 29 children referred to adenotonsillectomy 
for adenotonsillar hypertrophy. Serum IgA, IgM, and IgG and lymphocyte counts were analyzed at 
three points in time: before surgery, 1-2 months after surgery (short term), and 12-14 months after 
surgery (long term).
Results: TCD4+ cell counts were significantly increased shortly after surgery. IgA and IgG values 
were significantly reduced in the long run, but were within normal ranges for this age group.
Conclusion: This study indicated that adenotonsillectomy does not pose negative short or long term 
impacts upon the cellular and humoral immunity of children submitted to the procedure.
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INTRODUCTION
The palatine and pharyngeal tonsils, along with the 
lingual and tubal tonsils and the lateral pharyngeal bands 
are the Waldeyer’s ring most important structures1,2. They 
are secondary lymphoid organs part of the mucosa-asso-
ciated lymphoid tissue (MALT), which present immune 
activity mainly between four and ten years of age2.
Strategically located at the common entry point of 
the respiratory and digestive systems, they are the first 
point of contact between our bodies and a wide range of 
food and airborne antigens and microorganisms3-6.
From the histological point of view, the tonsils are 
organized in a manner closely related to their function in 
the immune system, and are divided into four compart-
ments, namely the reticular crypt epithelium, the extra-
follicular area, the mantle zones of lymphoid follicles, and 
the follicular germinal centers1-3.
The reticular crypt epithelium is made up by a 
system of 10 to 30 tonsil crypts that go from the surface 
to deeper levels1-3. Additionally, it hosts a complex system 
of specialized cells - M-cells and antigen-presenting cells 
(APC) - designed to imprison antigens and transport them 
through the epithelial barrier1-3,7.
In the extrafollicular area, dendritic cells and macro-
phages process antigens and present them to T-cells, which 
differentiate mainly into cytokine-producing T helper cells 
(CD4+), and cytotoxic or effector T-cells (CD8+)1-3,7.
In the follicular germinal centers, B-cells stimulated 
by T helper cells (CD4+) and cytokines start proliferating 
and turning into plasmocytes, which results in the pro-
duction of all sorts of immunoglobulins (IgG: ~65%, IgA: 
~20%, IgM, IgD, IgE), expansion of memory B-cell clones 
or migration of B-cells to distal sites. The overflow of blood 
lymphocytes onto the palatine tonsils and vice-versa is 
essential for the immune competence of these organs. The 
mantle zones are usually close to the crypt epithelium and 
contain predominantly naive B-cells, which are probably 
responsible for local immunity1-3,7.
Knowledge gathered on Waldeyer’s ring physiology 
and evidences on the contributions it makes to immune 
local and systemic response have been the topic of con-
troversy, in particular due to the injudicious manner in 
which adenotonsillectomy procedures have been carried 
out along the years. Thus, further research is required to 
analyze the possible immune adverse impact consequent 
to the procedure.
More recently, a wide range of studies have shown 
that the resolution of upper airway obstructions in pediatric 
patients after adenotonsillectomy has led to improved sleep 
and PSG test results, phonation with clearer and better 
voice, more significant growth and weight gain, resolution 
of nocturnal enuresis and behavior and neurocognitive 
disorders, and improved quality of life8.
Although adenotonsillectomy is the most commonly 
performed procedure in children7,9,10, its true impact upon 
the pediatric immune system is yet controversial. Few stu-
dies have looked into this matter to consider what happens 
to patients in the long run.
Therefore, this study aimed to verify the short and 
long-term impact of adenotonsillectomy by analyzing se-
rum markers for cellular and humoral immunity in children.
METHOD
This longitudinal prospective study was approved 
by the institution’s Research Ethics Committee and given 
permit 0582/07.
The parents or guardians of the subjects were 
informed of the purposes of this study, the tests patients 
would be offered, and the possible risks inherent to par-
ticipating in the study. Patients were only included in the 
study after their parents or guardians had read and signed 
an Informed Consent Term.
The patients
This study was the continuation of another study 
started back in 2008. Therefore, it reflected the long-term 
follow-up findings of some patients enrolled in the initial 
stages of a research project.
The initial stage of the study started in the pe-
riod between May and October of 2008, as 29 children 
aged between two and eight years (16 males and 13 fema-
les; mean age: 4.5 years) were enrolled. The patients were 
followed up by physicians from the ENT clinic. Subjects 
had been diagnosed with palatine and pharyngeal tonsil 
hypertrophy and prescribed adenotonsillectomy.
Patients were initially followed up for one to two 
months after surgery. At the end of this period they were 
assessed for short-term immune adverse impacts.
Still in this stage, the 29 subjects were divided into 
two groups based on their ages:
•	 Group I - children under four years of age.
•	 Group II - children aged four and above.
In the second stage of the study patients were tested 
again 12 to 14 months after surgery. Fourteen of the 29 
patients in the original group were tested again to verify 
the occurrence of adverse immune impact. This time they 
were not divided into different groups.
Personal and family history of immune deficiency 
or diseases with known immune-related etiology served 
as exclusion criteria.
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All patients were submitted to adenotonsillectomy 
with general anesthesia and orotracheal intubation. Tonsils 
were removed through cold dissection and adenoids using 
Beckman curettes.
Lab workup
Lab tests included humoral immunity serum marker 
levels - IgA, IgM, and IgG - and absolute T helper cell 
(TCD4+) and cytotoxic T-cell (TCD8+) counts.
Samples were collected at three different times: 
before surgery during anesthesia induction (sample 1); 
one to two months after surgery (sample 2); and 12 to 14 
months after surgery (sample 3).
The two first samples were collected for the 29 in-
dividuals enrolled in the first stage of the study. ANOVA 
tests were carried out on the data sets collected before 
surgery vis-a-vis short-term follow-up.
Paired data for the three samples (before surgery, 
short-term follow-up, and long-term follow-up) were ob-
tained for 14 of the 29 patients originally enrolled.
Immunoglobulin serum levels were determined 
through turbidimetry (Wiener® - Argentina). Subpopula-
tions of lymphocytes were identified by flow cytometry 
(Beckman Coulter® - U.S.). Immunoglobulin serum levels 
and absolute lymphocyte counts varying up to two stan-
dard deviations above or below the age-specific mean 
values were considered normal. Mean values reported in 
the literature were considered as reference values, as pro-
vided by the Pathology Lab at the Edmundo Vasconcelos 
Hospital, where all samples were tested.
Statistical analysis
Software package SPSS® version 16.0 (Chicago, U.S.) 
was used in the statistical analysis of the data. Variations on 
TCD4+ and TCD8+ counts and serum levels of IgA, IgM, 
and IgG before surgery and short-term follow-up (samples 
1 and 2/n = 29) were compared using Student’s t-test for 
paired samples. The Kolmogorov-Smirnov test was used 
to check the sample’s normal distribution.
The Friedman test was used to compare the three 
samples (n = 14).
Differences were statistically significant when 
p-values were under 0.05 (5% significance level).
RESULTS
Serum levels of cellular (absolute TCD4+ and 
TCD8+ counts) and humoral (IgA, IgM, IgG serum levels) 
immunity parameters and the mean variations between 
samples 1 & 2 of the 29 patients can be seen on Table 1. 
In the initial stage of the study, in which 29 patients were 
Table 1. Cellular and humoral immunity parameters, before 
surgery and during short-term follow-up (one to two months 
after surgery) (n = 29).
Before 
surgery
Short-term 
follow-up
Difference 
(95% CI) p
LTCD4+ 1.140 ± 563 1326 ± 507 186 (24-348) 0.026a
LTCD8+ 693 ± 294 675 ± 294 -18 (-119-82) 0.715
IgA 120 ± 59 126 ± 62 6 (-1-15) 0.094
IgM 122 ± 61 127 ± 57 5 (-2-12) 0.169
IgG 1004 ± 209 1010 ± 235 6 (-49-59) 0.840
Data presented as mean ± standard deviation. a p < 0.05 (Student’s 
t-test for paired samples): comparison between values before and 
after surgery.
enrolled, considering the global variation between samples 
1 & 2, there was a statistically significant increase of 186 
cells/mm3 in the absolute TCD4+ count (p < 0.05). TCD8+ 
counts were slightly reduced in sample 2, yet within nor-
mal ranges. Serum levels of IgA, IgM, and IgG in sample 
2 were not significantly increased (Table 1).
When patients were analyzed separately based on 
their ages, subjects on group I (under four years of age) 
had lower TCD8+ counts and IgG serum levels, albeit not 
significantly. TCD4+, IgA and IgM were increased, but not 
significantly.
Patients on group II (four years and above) 
had increased values in all assessed parameters, 
but statistical difference was seen only for TCD4+ count, 
with a mean increase of 230 cells/mm3 (p < 0.05) (Table 2).
Table 2. Cellular and humoral immunity parameters for group 
II, before and after surgery. (n = 15).
Before 
surgery After surgery
Difference 
(95% CI) p
LTCD4+ 981 ± 369 1211 ± 509 230 (27-433) 0.029a
LTCD8+ 663 ± 236 720 ± 335 57 (82-195) 0.394
IgA 160 ± 42 170 ± 40 10 (5-24) 0.178
IgM 131 ± 80 135 ± 74 4 (7-15) 0.435
IgG 1127 ± 161 1149 ± 189 22 (44-88) 0.485
Data presented as mean ± standard deviation. a p < 0.05 (Student’s 
t-test for paired samples): comparison between values before and 
after surgery.
The analysis of the results obtained for the group 
with 14 patients, for whom three samples were collected, 
indicated a statistically significant reduction on IgA and 
IgG levels in the long-term follow-up samples against 
preoperative and short-term follow-up samples. However, 
these values were still within normal range. TCD4+ and 
TCD8+ counts were slightly increased in the long-term 
follow-up samples, but failed to achieve statistical signi-
ficance (Table 3).
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Table 3. Cellular and humoral immunity parameters before 
surgery, during short-term follow-up (1 to 2 months) and long-
-term follow-up (12 to 14 months). (n = 14).
Before surgery Short-term follow-up
Long-term 
follow-up p
LTCD4+ 1165 ± 382 1374 ± 555 1545 ± 542 0.110
LTCD8+ 647 ± 393 630 ± 367 786 ± 225 0.210
IgA 136 ± 54 137 ± 53 106 ± 43 0.026a
IgM 140 ± 83 145 ± 73 120 ± 69 0.110
IgG 1070 ± 179 1037 ± 190 918 ± 182 0.002a
Data presented as mean ± standard deviation. a p < 0.05 (Friedman 
test): comparison between values before surgery and values observed 
in short and long-term follow-up.
None of the long-term follow-up patients had altered 
immunoglobulin or lymphocyte levels in their long-term 
samples except for one subject, whose IgA levels were 
slightly below reference values before surgery and were 
unaltered 14 months into follow-up.
DISCUSSION
The adverse immune impact of adenotonsillectomy 
in children has been studied for some time. Key studies 
connected to this topic were analyzed (Table 4).
Diverging reports have been presented in regards 
to short and long-term postoperative changes in immu-
noglobulin levels.
Veltri et al.22 reported statistically significant de-
creases - though within normal range - in IgG levels, 
whereas IgA, IgM, and IgD remained unaltered. Lal et al.11 
also found reduced IgG levels, although not lower than 
controls (p < 0.01). The same outcomes were reported by 
Friday et al.12 in the medium-term follow-up of adenoton-
sillectomy patients when compared to controls monitored 
clinically. The incidence of upper airway infections was 
not increased among patients in this study.
Cantani et al.13 and Kaygusuz et al.9 noticed a sig-
nificant medium-term follow-up decrease in IgA, IgM and 
Reference/year N Controls Age (years)
Follow-up 
(w, m, y) Postop humoral immunity Postop cellular immunity
Gogoi D14, 1979 10 20 5-14 3 m No significant alteration ND
Lal H11, 1984 40 40 5-15 1 m ¯IgG, to normal levels ND
Cantani13 A, 1986 65 65 2-11 1-4 m ¯IgA, IgM & IgG ND
Bussi M15, 1991 40 3-30 3 m ND CD3+, CD4+, CD8+ & B-cells
Friday G12, 1992 152 116 18-16 7-30 m ¯IgG ND
Böck A16, 1994 160 302 4-8 6 m-11 y ¯IgA CD21+ & ¯CD4+
Rio-Navarro B20, 1995 33 3-13 1 w - > 12 w ¯IgA (1-4 w);¯IgG (> 12 w), to normal values ND
Mira JGS17, 1998 30 30 3-15 1 & 12 m No significant alteration ND
Redondo F15, 2000 117 1-6 m No significant alteration ND
Jurkiewicz B3, 2002 80 40 3-14 1 & 6 m ¯IgA, IgM, IgG (1 m); IgA, IgM, IgG (6 m), to normal values ¯CD8+ (1 & 6 w), to normal values
Ikinciogullari A4, 2002 15 15 4-10 1-1.5 m No significant alteration ¯CD19+; CD3+, CD8+CD25+, CD19+CD23+
Kaygusuz I9, 2003 37 35 5-9 1 m ¯C3, C4, IgA, IgM, IgG; to normal values CD4+; ¯CD25+
Sebastiá L21, 2004 89 4-10 1 & 4 m ¯IgA, IgG (1 & 4 m); to normal values ND
Akker E18, 2006 63 60 2-8 12 m ¯IgA, to normal values ND
Faramarzi A10, 2006 102 2-15 2 & 8 w IgA (2 w); became normal (8 w) ¯CD17+ (2 w); (8 w)
Baradaranfar M6, 2007 30 30 4-10 6 m ¯IgG, to normal values TCD3+, TCD8+, BCD20+
Kaygusuz19, 2009 20 20 10-14 54 m No significant alteration ¯CD4 & CD19; CD16+65+ & CD25+
Table 4. Effects of adenotonsillectomy upon humoral and cellular immunity. Literature review.
Postop: postoperative; w: weeks; m: months; y: years; ND: not defined.
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IgG and concluded that the removal of the tonsils was 
not merely an anatomy-related event. Zielnik-Jurkiewicz 
et al.3 documented transient reductions in IgA, IgM and 
IgG (one month) followed by recovery onto normal va-
lues (six months). El-Ashmawy et al.23 followed patients 
for two months and saw significant reductions in IgA and 
IgG levels.
Unlike others, Gogoi et al.14, Redondo et al.24 and 
Ikinciogullari et al.4 did not find significant changes in 
immunoglobulin serum levels after adenotonsillectomy.
On the other hand, the effects upon cellular immuni-
ty have not been extensively studied and few publications 
on the topic are available4.
Baradaranfar et al.6 and Bussi et al.15 described 
significant increases in postoperative activated T and B 
cell counts. Ikinciogullari et al.4 observed reduced CD19+, 
and increased CD3+, CD8+CD25+, CD19+CD23+ counts.
In a paper published in 2003, Kaygusuz et al.9 found 
significant increases in TCD4+ and reduced CD25+ counts 
one month after surgery.
Decreased TCD8+ counts were reported by 
Zielnik-Jurkiewicz et al.3 at one and six months into 
follow-up, albeit in levels comparable to controls.
The long-term effects of adenotonsillectomy upon 
immunoglobulin levels and lymphocyte counts have been 
less studied, and few are the studies available on the topic.
Friday et al.12 did not report long-term alterations (16 
to 30 months) in IgA, IgM, and IgG levels in patients aged 
between one and 16 years. In a study with 106 patients 
followed up for a mean 6.6 years, Böck et al.16 published 
slight increases in CD21+ counts and reduced levels of 
CD4+ and IgA, all of which statistically significant. Howe-
ver, increases in the incidence of upper airway infections 
were not reported.
In 1996, Mira et al.17 followed 30 Brazilian patients 
aged between three and 15 years for one to 12 months. 
Minor reductions were reported on immunoglobulin levels, 
but they were not statistically significant.
Akker et al.18 analyzed 123 adenotonsillectomy pa-
tients for 12 months and reported significant decreased in 
IgA levels, although still within normal range.
In a study published in 2009, with the first part of 
the follow-up period published in 20039, Kaygusuz et al.19 
reported, after 54 months of follow-up, statistically signi-
ficant increases in CD4+ and CD19+ and reductions in 
CD16+56+ and CD25+ counts. No long-term alterations 
were found in immunoglobulin levels.
Antibody production by the tonsils was first obser-
ved in 1958 and, since then, they have been considered 
as active immune lymphoid organs, which manifest spe-
cific antibodies and T and B-cell activity in response to a 
wide range of antigens, performing humoral and cellular 
immunity functions3,16.
Diseases related to the tonsils are among the most 
common reasons why people see ENTs, with respiratory 
obstruction atop the list of complaints7.
Delayed diagnosis and treatment of these diseases 
may result in important consequences such as behavior 
alterations, low growth and weight gain, craniofacial al-
terations secondary to mouth breathing, mastication and 
swallowing disorders, in addition to cor pulmonale and 
left heart failure8.
Nonetheless, within the last few years the literature 
has described the benefits of adenotonsillectomy for chil-
dren with sleep-related obstructive respiratory disorder8.
Despite the many papers published within the last 
three decades on the immune impacts of adenotonsillec-
tomy in pediatric patients, there is no definite evidence 
that the procedure impairs the immune system.
However, still today patient family members and 
even physicians tend to believe that the removal of palatine 
and pharyngeal tonsils may result in impaired immunity.
A great deal of the controversy surrounding pos-
sible local or systemic immune involvement is derived 
from the comparison between the removal of chronically 
infected and/or hypertrophied tissue and the possible 
consequences of the elimination of an important defense 
barrier from the host4.
In order to facilitate the understanding of our results, 
the study was divided into two stages: the initial stage, in 
which short-term immune impacts of adenotonsillectomy 
(one to two months into follow-up) were analyzed for all 
children originally enrolled in the study; and the comple-
mentary stage, in which immune impacts 12 to 14 months 
after surgery were analyzed using the same lab tests in 14 
of the 29 original subjects.
Considering the analysis of the data from the first 
stage, no statistically significant differences were seen in 
IgA, IgM, and IgG levels.
Short-term follow-up TCD4+ counts were increa-
sed by a mean 186 cells/mm3 in relation to preoperative 
values (p < 0.05).
Graph 1 shows the mean variation between the 
parameters acquired before surgery and during short-term 
follow-up and their respective p values.
In order to investigate the possible impact of ade-
notonsillectomy upon the immune system of patients in 
various age ranges, the 29 subjects were further divided 
into two groups: one for individuals under four years of 
age (n = 14), and another with subjects aged four and 
above (n = 15).
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Graph 2. Humoral immunity serum markers. Mean variation in the re-
cent (1 to 2 months) and late (12 to 14 months) postoperative periods 
and 95% CI. IgA: Immunoglobuline A; IgM: Immunoglobuline M; IgG: 
Immunoglobuline G.
Graph 1. Humoral and cellular immunity serum markers. Mean 
postoperative variation and 95% CI. LTCD4+: Lymphocytes TCD4+; 
LTCD8+: Lymphocytes T CD8+; IgA: Immunoglobulin A; IgM: Immu-
noglobulin M; IgG: Immunoglubulin G.
No relevant immune impairment was seen in either 
of the groups separately. On the contrary, there was a 
significant increase in TCD4+ counts in Group II subjects 
(Table 2), who would theoretically be at a higher risk, as 
in this age range tonsil immune activity is more prominent.
The analysis of long-term follow-up samples of the 
14 patients enrolled in the complementary stage of the stu-
dy revealed a statistically significant reduction on IgA and 
IgG levels when compared to preoperative and short-term 
follow-up levels (Graph 2 and Table 3). Differently from 
short-term follow-up values, no significant alterations in 
TCD4+ and TCD8+ counts were seen (Table 3).
Our results agree with the literature, despite the 
significant divergence seen in the observations reported 
by other authors.
In general, more recent publications reported transient 
reduced antibody production (IgA and IgG in particular), 
though within normal range. Only two publications16,19 looked 
into the long-term variations in lymphocyte count and none 
showed adverse immune impact.
The origin of these alterations is still uncertain, but 
they may be related to surgical stress, reduction of immu-
noglobulin-producing lymphoid tissue, and reduction of 
antigen load3,6,9,12,18,21. Additionally, these alterations have 
not adversely impacted the frequency of occurrence or 
the severity of upper airway infection, differently from 
what was previously believed12,18,25.
Akker et al.18, on a controlled study (adenotonsillec-
tomy vs. clinical treatment), suggested that the remaining 
lymphoid tissue may compensate for the removal of the 
tonsils, once differences were not found between the 
values seen for both groups.
Nonetheless, it is believed that when these organs 
are involved with chronic inflammation, they do not per-
form a relevant role in protecting against upper airway 
infection, but inhibit immune response and increase in-
fection severity3,7,9.
TCD4+ and TCD8+ are involved in the regulation of 
B-cell response, which by its turn results in the production 
of immunoglobulins. In the extrafollicular zone, where 
antigens are processed, approximately two thirds of the 
T-cells are TCD4+. In situations of infection, however, 
marked proliferation of cytotoxic T-cells (TCD8+) has been 
observed with a consequent reversal on the TCD4+/TCD8+ 
ratio, resulting in early local and late systemic suppression 
of antibody production. B-cell activation is affected, thus 
leading to lesser availability of these cells. TCD4+ B-cell 
dependent response could also be impaired3,6.
Other important findings in the literature in-
dicate increased immunoglobulin and lymphocyte 
levels before surgery, supposedly due to chronic antigen 
stimulation of the tonsils3,9,11,22,25. Some authors consider it 
an important marker for disease, to assist in the decision 
of offering adenotonsillectomy to the patient at hand3,9.
From the global standpoint, therefore, current evi-
dence points to insignificant alterations in lab test results 
and failure to show that the removal of the tonsils leads 
to compromised immunity. Thus, still today the immune 
function of the pharyngeal and palatine tonsils and the 
possible effects of adenotonsillectomy upon the immune 
system are a matter of controversy.
Our complementary results reinforce the early fin-
dings of our study, which indicate that adenotonsillectomy 
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does not significantly impair immune function. Serum 
marker levels, albeit reduced, were kept within normal 
range. This is highly relevant in respect to the realm of 
clinical practice, as this finding becomes an important tool 
in advising patient family members and informing other 
assisting physicians over the actual impact of surgery.
Lastly, it is worthwhile making a few comments 
on the outcomes of this study. The difficulty keeping in 
touch with the patients in the long run prevented the 
enrollment of all 29 children in the complementary stage 
of the study. The reasons for this shortcoming include the 
H1N1 pandemics that manifested more intensely at the 
time the third sample was collected, thus driving people 
away from hospital settings, and the marked improvement 
from symptoms patients experienced after surgery. We 
opted to keep the data on the patients who did not take 
part in the last stage of the study to perform short-term 
analysis of variation and produce more meaningful results. 
The smaller sample in the end of the study did not allow 
subjects to be divided into different age groups.
The inclusion of a control group could have improved 
the legitimacy of our results.
CONCLUSION
The adenotonsillectomy pediatric patients enrolled 
in this study did not present short or long-term adverse im-
pacts upon their cellular or humoral immunity. Therefore, 
the procedure did not result in patient immune deficiency.
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